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httpUtility of direct angiosome revascularization and
runoff scores in predicting outcomes in patients
undergoing revascularization for critical limb
ischemia
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Objective: Both runoff scores and direct (DR) vs indirect revascularization (IR) according to pedal angiosomes have
unclear impact on outcome for patients with critical limb ischemia (CLI). We compared DR vs IR and runoff scores in
CLI patients undergoing infrapopliteal bypass for foot wounds.
Methods: Patients who had tibial/pedal bypass for a foot/ankle wound from 2005-2011 were identiﬁed and operations
classiﬁed as DR or IR based on wound location and bypass target. A blinded observer reviewed angiograms for an intact
pedal arch and calculated standard Society for Vascular Surgery (single tibial) and modiﬁed (composite tibial) runoff
scores. Comorbidities, wound characteristics, wound healing, major amputation, and overall survival were determined.
Results: A total of 106 limbs were revascularized in 97 patients; 54 limbs had DR and 52 had IR, although only 36% of
wounds corresponded to a single, distinct angiosome. Wound characteristics and comorbidities were similar between
groups. Mean standard (7.9 vs 7.2; P [ .001) and modiﬁed (22.2 vs 20.0; P [ .02) runoff scores were worse (higher
number indicates worse runoff) in the IR vs DR groups; 33% had a complete pedal arch. Complete wound healing (78% vs
46%; P [ .001) and time to complete healing (99 vs 195 days; P [ .002) were superior with DR vs IR but were not
inﬂuenced by runoff score, modiﬁed runoff score or presence of complete plantar arch. In multivariate models controlling
for runoff score, DR remained a signiﬁcant predictor for wound healing (odds ratio, 2.9; 95% conﬁdence interval, 1.1-7.4;
P [ .028) and reduced healing time (hazard ratio, 2.1; 95% conﬁdence interval, 1.2-3.7; P [ .012). Mean amputation-
free survival (75 vs 71 months for DR vs IR; P[ .82) and median survival (36 vs 33 months DR vs IR; P[ .22) were not
different for DR vs IR.
Conclusions: DR according to pedal angiosomes provides more efﬁcient wound healing, but is possible in only one-half of
the patients and does not affect amputation-free or overall survival. DR is associated with improved runoff scores, but
current runoff scores have little clinical utility in predicting outcomes in CLI patients. (J Vasc Surg 2014;59:121-8.)The angiosome concept of vascular anatomy deﬁnes
three-dimensional vascular territories that are fed by distinct
source arteries.1 Anatomic studies deﬁning speciﬁc angio-
somes began in the 1970s in plastic surgery as a means to
optimize tissue transfer. Over the last several years, the
concept has been applied to critical limb ischemia (CLI) as
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://dx.doi.org/10.1016/j.jvs.2013.06.075planning distal revascularization. The central argument in
favor of an angiosome-based approach is that establishing
direct arterial ﬂow to an ischemic region will provide the
best chance for wound healing and limb salvage.2
Tibial bypass for limb salvage in CLI is not a new
concept. Studies have demonstrated the beneﬁt of bypass
to the peroneal artery for pedal gangrene3 and to the dor-
salis pedis (DP) artery for heel wounds.4 Although not
speciﬁcally designed to do so, from an angiosome perspec-
tive, these target vessels represent indirect revascularization
(IR). Because both studies demonstrated successful limb
salvage, the ﬁndings could be used to argue against the
beneﬁts of an angiosome-based revascularization. Recent
studies have examined the beneﬁt of angiosome-oriented
revascularization in both open5-7 and endovascular proce-
dures.8-11 Despite extensive study, the concept has not
been widely accepted. Most critics believe that regardless
of which angiosome is revascularized, bypasses to any of
the three crural arteries should provide adequate inﬂow
to the entire foot because of the presence of collateral
vessels.6 Given this ongoing controversy, the primary
purpose of our study was to compare rates of wound
healing and limb salvage for patients undergoing direct121
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were to examine the feasibility of angiosome-directed
revascularization and to compare this approach with the
Society for Vascular Surgery (SVS) runoff score to evaluate
the utility of each in predicting wound healing.
METHODS
The study was approved by the Institutional Review
Board at Oregon Health and Science University. We
conducted a retrospective review of our prospectively main-
tained operative database from2005-2011. After identifying
all lower extremity bypass procedures, we included only
those patients who had a bypass to the peroneal, posterior
tibial (PT), anterior tibial (AT), or DP arteries. We do not
use prosthetic conduit for below-knee bypasses, and thus,
all procedures used the autogenous vein. Patients with distal
anastomoses at a more proximal level were excluded. We
then limited our cohort to those patients with foot and/or
ankle wounds to identify the primary affected angiosome.
Charts were reviewed for demographic information and
comorbidities. Preoperative clinic notes were used to deter-
mine wound location, duration of wound prior to interven-
tion, as well as wound dimension. Based on the documented
wound location, a primary angiosome was assigned to each
lesion based on published reports detailing the skin and
subcutaneous tissue perfused by each source artery.2 In addi-
tion, the presence of active infection or osteomyelitis as
conﬁrmed on pathologic specimen was noted as well.
Preop pulse examination and ankle-brachial index (ABI)
were recorded as documented in the medical record. To
characterize arterial inﬂow, all patients had an angiogram
performed preoperatively. For the purposes of our study,
these angiograms were reviewed by a board-certiﬁed radiol-
ogist (D.C.), who had no knowledge of the location of each
individual’s foot wound, nor the target artery that was ulti-
mately used in each bypass operation. Images were scored
using the SVS standards for calculating runoff score, which
included assessment of whether the pedal arch was intact.12
The runoff score is a numerical scale from1-10 that takes into
account the speciﬁc outﬂow vessels as well as the degree of
stenosis in each vessel for any given bypass procedure, with
1 representing very little resistance and 10 representing
maximal resistance to ﬂow. In isolated tibial artery bypasses,
one additional point is added for bypasses to the peroneal
artery, to account for the lack of direct connection to the
pedal circulation.12 Thus, a patient with a bypass to a distally
occluded peroneal artery would actually be assigned a runoff
score of 11. Pedal vessels are scored according to the
following scale: 3 - no primary pedal artery patent; 2.5 -
partially patent or fully patent beyond critical in-line occlu-
sive lesion; 2 - in-line continuity with patent outﬂow vessel,
but incomplete arch (IPA); 1 - one or more subcritical
stenoses but no in-line stenosis; and 0 - fully patent pedal
run-off (<20% stenosis). The runoff score was calculated
for each patient based on their eventual bypass target. In
an attempt to determine the overall burden of vascular
disease in each affected limb, we calculated a “modiﬁed
runoff score” for each patient, which was essentially thesum of the occlusion scores for each of the tibial vessels
(AT, PT, and peroneal) as well as their respective pedal
branches (AT eDP; PT emedial calcaneal, medial plantar,
lateral plantar; and peroneal e anterior perforating branch,
calcaneal branch). Under this novel scheme, a limb with all
tibial arteries and all subsequent terminal branches occluded
would receive a maximum modiﬁed runoff score of 27,
whereas a limb with fully patent tibial vessels and terminal
branches would receive a score of zero. The modiﬁed runoff
score was intended as a surrogate marker for collateraliza-
tion. We postulated that those with lower modiﬁed runoff
scores have more preserved runoff and thus increased collat-
eral blood ﬂow regardless of whether a DR vs IR was
performed.
All patients underwent open bypass with autogenous
conduit. When available, a single segment of saphenous
vein was used. When saphenous vein of sufﬁcient length
and caliber was not available, composite venous conduits
were created using segments of saphenous and/or arm
vein (basilic or cephalic). Based on preoperative vein
mapping studies, we recorded the average and minimum
diameters of the conduit used in each patient. The distal
target vessel was selected by the primary operating surgeon
based on its angiographic appearance, the perceived quality
of the target vessel, and the length of conduit available.
During bypass planning, no consideration was given to
whether the operation would provide DR vs IR. Our
typical practice is to select the most proximal site on the
target vessel that will allow for distal ﬂow to the ischemic
foot. Based on prior experience at our institution demon-
strating equivalent outcomes for peroneal vs inframalleolar
bypass targets for pedal gangrene,3 we do not make
exhaustive efforts to bypass to the foot unless this is the
most proximal patent arterial segment.
For the purposes of our analyses, each bypass was clas-
siﬁed as either a DR or IR based on the relationship of the
target vessel to the primary wound location. Based on
previously published studies, DR was deﬁned as bypass to
the artery supplying the source vessel of the primary
affected angiosome5 (Table I). For heel wounds, bypasses
to either the peroneal or PT artery were both considered
DR because of the dual blood supply to this region. Like-
wise, for isolated toe wounds, bypasses to either the DP or
the PT artery were considered DRs. Other bypass target/
wound combinations were considered IRs.
Wound outcome was determined by reviewing postop-
erative records. Primary healing as well as minor and/or
major amputation date was noted. Secondary interven-
tions, wound recurrence, and incisional complications
such as dehiscence or incisional wound infection were
recorded as well. Wounds were considered healed when
chart review documented that the wound bed had
completely re-epithelialized. Currently, we do not have
a dedicated wound center outside of our clinic. In general,
small wounds are treated with standard wound dressings,
whereas in larger wounds we often use commercially avail-
able negative pressure wound dressings. As long as infec-
tion is controlled, we allow wounds whatever time
Table II. Patient characteristics
Overall
(n ¼ 106)
IR
(n ¼ 52)
DR
(n ¼ 54)
P value
(t-test)
Age 67.8 years 68.6 years 67.0 years .53
Height (n ¼ 76) 1.73 m 1.75 m 1.71 m .15
Weight (n ¼ 80) 87.2 kg 87.5 kg 86.8 .89
BMI (n ¼ 76) 28.5 27.7 29.2 .37
No. (%) No. (%) No. (%)
P value
(c2)
Sex .90
Male 74 (70) 36 (69) 38 (70)
Female 32 (30) 16 (31) 16 (30)
CAD 50 (47) 30 (58) 26 (48) .33
Valvular disease 11 (10) 6 (12) 5 (9) .70
Arrhythmia 21 (20) 11 (21) 10 (19) .73
CHF 18 (17) 7 (14) 11 (20) .34
Cerebrovascular
disease
31 (29) 14 (27) 17 (31) .61
HTN 81 (77) 38 (73) 43 (80) .43
COPD 6 (6) 2 (4) 4 (7) .43
Smoking .62
Current 25 (24) 14 (27) 11 (20)
Former 42 (40) 21 (40) 21 (39)
Never 39 (37) 17 (33) 22 (41)
Chronic renal
disease
35 (33) 17 (33) 18 (33) .94
Dialysis 13 (12) 4 (8) 9 (17) .16
Mean Cr 1.7 mg/dL 1.6 mg/dL 1.8 mg/dL .35a
Hyperlipidemia 43 (41) 23 (44) 20 (37) .45
Diabetes mellitus 67 (63) 29 (56) 38 (70) .12
HgbA1C (mean,
n ¼ 35)
6.9% 6.7% 7% .39a
Statin use 53 (50) 28 (55) 25 (46) .38
Antiplatelet use 67 (63) 35 (70) 32 (59) .25
BMI, Body mass index; CAD, coronary artery disease; CHF, congestive
heart failure; COPD, chronic obstructive pulmonary disease; Cr, creatinine;
DR, direct revascularization; Hgb, hemoglobin; HTN, hypertension.
at-test.
Table I. Lower extremity arteries and their associated
vascular territories (ie, angiosomes)
Artery Anatomic distribution
PT
Medial calcaneal branch Medial ankle, plantar heel
Medial plantar branch Medial plantar instep
Lateral plantar branch Lateral forefoot, plantar midfoot,
plantar forefoot
AT
DP Dorsum of foot
Peroneal
Lateral calcaneal branch Lateral ankle, plantar heel
Anterior branch Anterior upper ankle
AT, Anterior tibial; DP, dorsalis pedis; PT, posterior tibial.
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to heal, or those in which infection cannot be contained
with local wound care alone are considered for either minor
or major amputation. We typically favor minor amputations
when possible to preserve limb function. Limbs that
required minor amputation (toe, ray, or transmetatarsal
amputation), but ultimately healed were considered
successful limb salvage. Limbs that required major amputa-
tion (above- or below-knee) were considered nonhealed.
Survival was determined by reviewing both the electronic
medical record and the Social Security Death Index.
Statistical analysis was performed using IBM SPSS
Statistics v. 20 (IBM Corporation, Armonk, NY). Categor-
ical variables were compared using c2 analyses. Normally
distributed continuous variables were compared using
independent sample t-tests. Runoff score was compared
using a Mann-Whitney U test. Multivariate analysis was
used to compare wound healing between DR and IR
groups while controlling for runoff score. Time to
complete wound healing, major amputation-free survival,
and overall survival were calculated using the Kaplan-
Meier method with differences compared using the log-
rank test.
RESULTS
From January 2005 through December 2011, 375
lower extremity arterial bypasses were identiﬁed. After
excluding those patients who underwent bypass to
a more proximal vessel, and those without a clearly deﬁned
foot wound, 106 lower extremity bypasses performed in
97 were included. Patient characteristics were similar for
those who underwent DR vs IR (Table II).
The average wound duration prior to intervention was
90 days and was not signiﬁcantly different between DR vs
IR (66 vs 116 days; P ¼ .09) nor between those with
wounds that ultimately healed vs those that did not
(healed, 102 days vs nonhealed, 71 days; P ¼ .30). Infec-
tion was present in 60% (n ¼ 64) of patients while 21%
(n ¼ 22) had evidence of osteomyelitis. Rates of both
infection and osteomyelitis were similar between DR and
IR groups as well as between those with healed vs non-
healed wounds. Likewise, the presence of diabetes didnot have a signiﬁcant impact on wound healing by c2 anal-
ysis (P ¼ .71). Documentation of wound area was only
available in 36 patients, but was comparable between DR
vs IR (5.5 vs 4.6 cm2; P ¼ .68) and between wounds
that healed and those that did not (4.0 vs 6.8 cm2;
P ¼ .18).
Only 36% (n ¼ 38) of wounds could be assigned to
a single, distinct angiosome (Table III). Eleven wounds
were located within the AT/DP angiosome, 15 in the
PT, and 12 in the peroneal artery angiosome, respectively.
Conversely, 59 (56%) wounds involved both the DP and
PT angiosome. These were primarily toe wounds. Eight
wounds involved portions of all three major angiosomes
(DP, PT, and peroneal), while one involved both the PT
and peroneal angiosomes. Bypass was performed to the
AT in 29 (27%) patients, to the DP in 13 (12%), to the
PT in 31 (29%), to the peroneal artery in 32 (30%) and
to a branch of the medial plantar in one patient
(Table IV). Among those patients who had a bypass to
the peroneal artery, 31 of 32 bypasses were considered
IRs. Overall, there were 54 DRs and 52 IRs. The DR
Table IV. Target vessel
Bypass target artery
Overall,
No. (%)
IR,
No. (%)
DR,
No. (%) P value (c2)
AT 29 (28) 13 (25) 16 (30) .59
DP 13 (13) 2 (4) 11 (20) .01a
PT 31 (29) 6 (12) 25 (46) <.001a
Peroneal 32 (30) 31 (60) 1 (2) <.001a
Plantar branch 1 (1) 0 1 (2) .32
AT, Anterior tibial; DP, dorsalis pedis; DR, direct revascularization;
IR, indirect revascularization; PT, posterior tibial.
aP < .05.
Table III. Wound location by primary angiosome
Angiosome(s)
Overall,
No. (%)
IR,
No. (%)
DR,
No. (%) P value (c2)
DP 11 (10) 8 (15) 3 (6) .1
PT 15 (14) 11 (21) 4 (7) .04a
Peroneal 12 (11) 5 (10) 7 (13) .59
PT/peroneal 1 (1) 1 (2) 0 .3
DP/PT 59 (56) 21 (40) 38 (70) .002a
DP/PT/
peroneal
8 (8) 6 (12) 2 (4) .13
DP, Dorsalis pedis; DR, direct revascularization; IR, indirect revasculari-
zation; PT, posterior tibial.
aP < .05
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wound location, as well as distal bypass target artery
(Tables III and IV).
All bypass procedures used autogenous vein as
conduits. Eighty-seven operations (82%) used a segment
of saphenous vein, while individual segments of cephalic
vein were used in six (6%) limbs and basilic vein in two
(2%). Composite grafts were used in 11 total operations:
six (6%) were combined arm and leg vein segments, three
(3%) were combined arm vein, and two (2%) were
combined leg vein. Preoperative vein mapping studies
were available in 104 patients. Mean vein diameter was
4.6 6 1.0 mm while the minimum vein diameter recorded
in each patient averaged 3.1 6 0.79 mm.
The mean preoperative ABI in the affected extremity
was 0.47 6 0.28 and did not differ between DR vs IR
groups (0.41 6 0.2 vs 0.54 6 .33; P ¼ .06). Mean postop-
erative ABI was 0.95 6 0.24. Postoperative ABIs were
statistically higher following DR vs IR (1.0 6 0.28 vs
0.90 6 0.18; P ¼ .04). However, the clinical signiﬁcance
of this ﬁnding is questionable, as both values are in the range
of normal perfusion. Furthermore, the mean postop ABI
was similar in patients with wounds that healed vs those
that did not (healed: 0.94 6 0.23 vs unhealed: 0.96 6
0.25; P ¼ .79), suggesting that this was not a factor in
wound healing. Ninety-two limbs (87%) had angiographic
imaging available for review. In 14 others, imaging was per-
formed at a referring institution, but was unavailable for
review at the time of data collection. In 85 of 106 limbs,
preoperative angiography was sufﬁcient to classify the
plantar arch. In these patients, the pedal vessels were scored
according to the scale used to calculate the SVS runoff score.
Of this group, 28 (33%) had a complete plantar arch (CPA),
whereas 57 (67%) had an IPA. The number of patients with
a CPA was similar between DR and IR groups (13 vs 15
patients; c2; P ¼ .59).
The mean runoff score was 7.26 2.2, and was worse in
patients who underwent IR compared with those who had
DR (7.9 6 2.2 vs 6.6 6 2.0; P ¼ .001). The mean modi-
ﬁed runoff score was 21.1 6 4.3 and was higher in those
who underwent indirect as opposed to DR (22.2 6 2.5
vs 20.0 6 4.7; P ¼ .02). After reviewing preoperative
angiograms, 66 patients had at least partially patent vesselsin the primary affected angiosome, suggesting that DR
could have been attempted in these patients. Fifty-four of
these 66 patients did have DR, leaving 12 (23%) patients
who had IR but who may have actually been eligible
for DR.
Primary wound healing was attained in 28 limbs
following bypass, whereas minor amputation was required
to achieve wound healing in 38 patients. Twelve others
required major amputation. Sixteen patients were lost to
follow-up before complete wound healing was achieved,
while 11 died with nonhealed wounds. A greater propor-
tion of patients required minor amputation in the DR
group (46% vs 25%; P ¼ .02), although signiﬁcantly
more patients in the IR group were lost to follow-up or
died with persistent wounds (Table V). Complete wound
healing was achieved in 65 patients (61%) and was more
likely to occur in patients undergoing DR vs IR (78%,
n ¼ 41 vs 46%, n ¼ 24; P ¼ .001).
Time to complete wound healing was signiﬁcantly
shorter with DR (DR, 99 6 27 days vs IR, 195 6
67 days; log-rank, P ¼ .002; Fig 1). Neither the traditional
runoff score nor our modiﬁed runoff score were signiﬁ-
cantly different between wounds that healed and those
that did not. Comparing patients with and without
a CPA revealed similar wound healing between groups
(IPA: 63%, n ¼ 36 vs CPA: 68%, n ¼ 19; P ¼ .67), as
well as median time to complete wound healing as deter-
mined by Kaplan-Meier analysis (IPA, 124 days vs CPA,
116 days; log-rank, P ¼ .64). Finally, we performed multi-
variate analysis to eliminate bias introduced by variable
runoff between DR and IR groups. Controlling for runoff
score, DR remained a signiﬁcant predictor of both wound
healing (odds ratio, 2.9; 95% conﬁdence interval, 1.1-7.4;
P ¼ .028) and decreased healing time (hazard ratio, 2.1;
95% conﬁdence interval, 1.2-3.7; P ¼ .012).
Despite signiﬁcant differences in wound healing, major
amputation-free survival was similar between DR and IR
groups. With six major amputations in each group, mean
amputation-free survival was 70.9 6 11 months for IR
and 75.3 6 8 months for DR (log-rank, P ¼ .82; Fig 2).
Amputation-free survival was likewise similar for patients
with complete vs incomplete pedal arch, respectively
(72 6 9.1 vs 65 6 8.8 months; log rank, P ¼ .86). Median
survival was only 34 6 5.4 months for the entire cohort
Table V. Ultimate limb outcome
Limb outcome
Overall,
No. (%)
IR,
No. (%)
DR,
No. (%)
P value
(c2)
Major amputation 12 (11) 6 (12) 6 (11) .95
Minor amputation,
wound healed
38 (36) 13 (25) 25 (46) .02a
No amputation,
wound healed
28 (27) 11 (21) 17 (31) .23
Lost to follow-up,
persistent wound
16 (15) 13 (25) 3 (6) .005a
Died, persistent wound 11 (11) 9 (18) 2 (4) .02a
Still followed, not healed 1 (1) 0 1 (2) 1
DR, Direct revascularization; IR, indirect revascularization.
aP < .05.
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groups (36.2 6 6.0 months vs 33.1 6 7.2 months; log-
rank, P ¼ .22).
DISCUSSION
Our ﬁndings suggest that in distal bypass for CLI, DR
to an ischemic angiosome is more likely to lead to complete
wound healing than IR. Furthermore, wounds healed
almost 3 months faster with DR vs IR. Neither SVS runoff
score nor our modiﬁed runoff score were signiﬁcant predic-
tors of outcome. Despite improved wound healing, DR did
not inﬂuence major amputation-free survival. However,
decreased time spent with an open wound may increase
patients’ quality of life in addition to decreasing the costs
associated with ongoing wound care. Median survival was
limited overall, but appeared unaffected by revasculariza-
tion strategy. Survival in our cohort is typical of patients
with CLI, who typically have signiﬁcant comorbidities
and an increased risk of cardiovascular morbidity and
mortality.13 By limiting our study to patients undergoing
distal bypass and those with evidence of tissue loss, we
have selected a subset of patients at the extreme end of
the CLI spectrum, which likely explains the dismal overall
mortality observed in our study population.
Prior to studies investigating the angiosome concept,
a study from our institution compared peroneal and infra-
malleolar bypass for ischemic ulcers and demonstrated
similar results for primary patency, limb salvage and
3-year survival with either approach.3 Equivalent results
were attained even in those without angiographically
identiﬁable collateral vessels, suggesting that distal bypass
procedures improve ﬂow to the entire foot, rather than
a more limited area. These ﬁndings argue against the
importance of angiosome-based revascularization. How-
ever, that study included a greater number of heel ulcers
in patients who underwent peroneal bypass compared
with those who underwent inframalleolar bypass (29% vs
3%; P ¼ .006).3 By the angiosome model, bypass to the
peroneal artery for a heel ulcer would be considered a DR.
Reports dealing speciﬁcally with angiosome-based
distal bypass offer mixed results. Neville et al5 performed
a retrospective analysis of DR vs IR and compared theeffect on wound healing and limb salvage. DR was associ-
ated with a signiﬁcantly higher rate of complete wound
healing than IR (90.9% vs 61.9%; P ¼ .03). Fewer amputa-
tions were observed in the DR group, but this was not
signiﬁcantly different. In addition, time to complete wound
healing was not signiﬁcantly different between groups.
Unlike our study, the Kaplan-Meier method was not
used to analyze time to complete wound healing.
We mirrored the classiﬁcation scheme used by Neville
et al to deﬁne direct vs indirect bypass to an ischemic
angiosome. This scheme describes bypasses to the parent
arteries of each angiosome (AT, PT, and peroneal) rather
than the six pedal angiosomes originally described by
Attinger.2 However, that original paper suggests that
“revascularization of the artery directly supplying the
ischemic/ulcerated angiosome should be more successful
than revascularizing one of the other two major arteries.”2
When performing open bypass operations, bypass to the
AT, PT, or peroneal arteries provides a more practical
option when compared with inframalleolar bypass in terms
of both length of conduit required and caliber of the target
artery.
In contrast, a larger, more recent study observed signif-
icant differences in preoperative wound characteristics and
bypass targets between patients undergoing DR vs IR,
challenging the validity of direct comparison of these two
groups.6 After matching DR and IR patients by
propensity-score, both healing rate and limb salvage were
similar between groups. Instead, the presence of end-
stage renal disease (ESRD) was the strongest predictor of
clinical failure, leading authors to conclude that in most
non-ESRD patients, the angiosome concept is not highly
important. While it was difﬁcult to characterize wounds
extensively in our patients, average wound dimensions
and duration prior to operation were similar between the
DR and IR groups. Furthermore, patients in the Azuma
series6 had high rates of diabetes (81%) and dialysis-
dependent ESRD (49%). In contrast, only 63% of our
patients had diabetes and only 33% had evidence of chronic
renal insufﬁciency (serum creatinine >1.5 mg/dL) with
only 12% of all patients on dialysis. Diabetic patients and
those with ESRD often have a greater degree of microvas-
cular disease than nondiabetic patients and those with
normal renal function. As a result, these patients would
likely have less collateralization between adjacent regions
of the foot. In that case, it would seem that selecting
a bypass target that was in close proximity to an ischemic
wound would be even more important, thereby enhancing
the importance of the angiosome concept.
In a mixed cohort of open and endovascular interven-
tions, DR was associated with improved ulcer healing (92%
vs 73% at 12 months; P ¼ .008) and improved limb salvage
at 48 months (93% vs 72%; P ¼ .2) when compared with
IR.7 However, to assess the role of collateral ﬂow on
wound healing, investigators also compared DRs with
IRs in patients with intact collateral vessels and found no
difference in ulcer healing rate or limb salvage between
DR and IRc, leading to the critique that the angiosome
Fig 1. Time to complete wound healing. Standard error (SE) noted at last time point depicted in the ﬁgure. SE did not
exceed 10% during this period. DR, Direct revascularization; IR, indirect revascularization.
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eral vessels. We did not directly assess the role of ﬂow via
collaterals on wound healing. Instead, we attempted to
use the runoff score as a surrogate measure of collateraliza-
tion. By deﬁnition, the runoff score is calculated based on
distal target vessel, and as such, we did not believe that this
would provide an adequate representation of the degree of
collateralization within a given limb. As a result, we also
calculated a modiﬁed runoff score for each patient, incor-
porating all major below-knee vessels. Both traditional
and modiﬁed runoff scores were signiﬁcantly higher in
patients undergoing IR, although neither runoff scoring
scheme correlated with wound healing or limb salvage.
This is not altogether surprising, since runoff score has
largely been validated as a predictor of bypass patency as
opposed to wound healing and with prosthetic rather
than autogenous bypass conduits. Since the ultimate goal
of any revascularization is limb salvage, the runoff score
may not be a relevant assessment tool.
As an additional attempt to assess collateralization in
the affected extremity, we performed separate analyses
according to the presence or absence of a complete pedal
arch. Taken alone, the presence of a complete pedal arch
did not confer a beneﬁt in terms of the percent of patients
achieving complete wound healing or the time to complete
wound healing. In addition, the proportion of patients with
a complete arch was statistically similar in both the DR and
IR group. As a result, improvements in wound healing in
the DR group may be attributed to the target vessel itself(ie, DR vs IR) rather than the presence of a more devel-
oped network of collateral vessels.
Despite the beneﬁts of DR demonstrated by our data,
the angiosome concept does have its limitations. First, only
36% of wounds were within the boundaries of a single
angiosome. The remaining wounds crossed the borders
of two or even three angiosomes. In this case, it may be
difﬁcult to determine the primarily affected angiosome
and, therefore, to select the vessel that will allow for DR.
However, redundant blood supply in the heel (PT and
peroneal arteries) and in the toes (DP and PT arteries)
does increase the number of vessels available for DR in
these areas. In addition, as noted by Alexandrescu,8 there
are anatomic variations whereby angiosomes may not be
perfused by the predicted source artery. In our retrospec-
tive study, we did not account for such variations, which
may confound our classiﬁcation of bypasses as “direct” vs
“indirect.” However, these anatomic variants were rela-
tively infrequent in Alexandrescu’s series (16%) and may
actually represent dilated collateral arteries as a result of
long-standing peripheral arterial disease. In addition, “a
common trunk for the AT and peroneal arteries”8 as that
group described would not necessarily alter the distal
extent of these arteries. As a result, bypass to these vessels
would still perfuse the regions predicted by the angiosome
model.
In addition, patients with severe CLI often rely on
a single tibial vessel to provide ﬂow to the foot. As a result,
DR may not be possible in all patients. In our series,
Fig 2. Major amputation-free survival. Standard error (SE) exceeded 10% at the 5-year time point. DR, Direct
revascularization; IR, indirect revascularization.
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This meant that only 12 of 52 (23%) who underwent IR
may actually have been eligible for DR. Using subintimal
recanalization techniques, endovascular therapy may allow
DR in a greater number of patients. This approach has
been analyzed multiple series and has demonstrated supe-
rior wound healing and limb salvage with DR.8,11 While
angioplasty is associated with decreased long-term patency
vs bypass surgery, the metabolic demands required to heal
active wounds are much greater than those of a healed
extremity, and thus, the consequences of re-occlusion
may be less once a wound has healed.
Our study is subject to many of the limitations of
a retrospective study. First, detailed information to charac-
terize wounds was lacking in more than one-half of our
patients. Despite limited baseline data, that available
suggests that wound size was similar in both DR and IR
groups as well as between healed and unhealed wounds.
In addition, 15% of all patients were lost to follow-up
before their wounds had healed completely, with a greater
number of these occurring in the IR group. On one hand,
this may reﬂect the inferior wound healing demonstrated in
these patients. This argument is strengthened by the fact
that a greater proportion of patients in the IR group died
with persistent wounds vs those in the DR group. It is
also possible that patients with nonhealing wounds were
lost to follow-up because they sought additional care else-
where. However, as the only academic referral center in
Oregon, these complicated patients are frequently referredto us by vascular surgeons around the state. While baseline
demographic factors were similar between groups, we
cannot exclude the possibility that there may have been
inherent differences in disease severity between the DR
and IR groups. Although by no means deﬁnitive, our
results do provide additional data that will hopefully form
the basis for prospective studies of angiosome-based
revascularization.
CONCLUSIONS
For patients with CLI undergoing distal bypass proce-
dures, DR and IR offer similar rates of limb salvage.
However, DR is more likely to lead to complete wound
healing in patients with ischemic ulcers. Furthermore, the
time required for complete wound healing is signiﬁcantly
less with DR than with IR. Although DR is associated
with improved runoff scores, runoff score itself has little
clinical utility in predicting outcomes in CLI patients.
Our ﬁndings would be strengthened by further prospective
evaluation of the angiosome-directed revascularization.
Although not possible in all patients, when arterial anatomy
allows, DR should be the preferred bypass strategy for
ischemic lower extremity wounds.
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